Numerous UT MD Anderson Meet the Experts sessions are scheduled throughout ESMO.
Friday, October 23 (All times in CEST)
11:00–11:30 (11–11:30 a.m.)
The new era of KRAS-directed therapy
Marcelo Vailati Negrao, M.D.
Assistant Professor, Thoracic/Head and Neck Medical Oncology
13:30–14:00 (1:30–2 p.m.)
Defining the future of breast cancer care, Part 1
Carlos Barcenas, M.D.
Professor, Breast Medical Oncology
14:00–14:30 (2–2:30 p.m.)
Harnessing ctDNA across the cancer continuum
Arvind Dasari, M.D.
Professor, GI Medical Oncology
16:00–17:00 (4–5 p.m.)
The next generation of immunotherapies, Part 1
Stéphane Champiat, M.D., Ph.D.
Associate Professor, Investigational Cancer Therapeutics
Saturday, October 24 (All times in CEST)
10:30–11:00 (10:30–11 a.m.)
Shaping tomorrow's gynecologic cancer care
Amir Jazaeri, M.D.
Professor, Gynecologic Oncology and Reproductive Medicine
Shannon Westin, M.D.
Professor, Gynecologic Oncology and Reproductive Medicine
10:30–11:00 (10:30–11 a.m.)
The next generation of immunotherapies, Part 2
Hussein Tawbi, M.D., Ph.D.
Professor, Melanoma Medical Oncology
Professor, Investigational Cancer Therapeutics
Executive Director, Immuno-Oncology Clinical Drug Development Program
11:00–11:30 (11–11:30 a.m.)
New horizons in head and neck cancer care
Renata Ferrarotto, M.D.
Professor, Head and Neck Medical Oncology
Neil Gross, M.D.
Professor, Head and Neck Surgery
Luana Guimaraes de Sousa, M.D.
Assistant Professor, Head and Neck Medical Oncology
11:00–12:00 (11 a.m.–12 p.m.)
Patient-centered palliative care
David Hui, M.D.
Professor, Palliative Care and Rehabilitation Medicine
11:30–12:00 (11:30–12 p.m.)
Decoding the latest leukemia advances, Part 1
Courtney DiNardo, M.D.
Professor, Leukemia
13:00–13:30 (1–1:30 p.m.)
Clinical trials at UT MD Anderson
Jennifer Litton, M.D.
Chief Clinical Research Officer
13:00–13:30 (1–1:30 p.m.)
Defining the future of breast cancer care, Part 2
Sharon Giordano, M.D.
Chair and Professor, Breast Medical Oncology
Sunday, October 25 (All times in CET)
10:15–10:45 (10:15–10:45 a.m.)
Transforming outcomes in genitourinary cancers
Omar Alhalabi, M.D.
Associate Professor, Genitourinary Medical Oncology
Andrew Hahn, M.D.
Assistant Professor, Genitourinary Medical Oncology
Andrew Johns, M.D.
Assistant Professor, Genitourinary Medical Oncology
11:00–11:30 (11–11:30 a.m.)
Accelerating discoveries with industry partnerships
Emily Barnhill
Vice President, Strategic Industry Ventures
11:30–12:00 (11:30–12 p.m.)
Hereditary cancer in the era of precision oncology, Part 1
Banu Arun, M.D.
Professor, Breast Medical Oncology
Professor, Clinical Cancer Prevention
13:00–13:30 (1–1:30 p.m.)
From target to therapy: Advances in drug discovery
Tim Heffernan, Ph.D.
Vice President and Head of R&D, Therapeutics Discovery
Timothy Yap, M.B.B.S., Ph.D.
Vice President, Head of Clinical Development, Therapeutics Discovery Division
Professor, Department of Investigational Cancer Therapeutics
14:00–14:30 (2–2:30 p.m.)
The expansion of antibody drug conjugates
Ana Aparicio, M.D.
Professor, Genitourinary Medical Oncology
Apostolia Tsimberidou, M.D., Ph.D.
Professor, Investigational Cancer Therapeutics
17:00–17:30 (5–5:30 p.m.)
Hereditary cancer in the era of precision oncology, Part 2
Eduardo Vilar-Sanchez, M.D., Ph.D.
Professor and Chair Ad Interim, Clinical Cancer Prevention
Professor, Gastrointestinal Medical Oncology
Maria Iniesta-Donate, M.D., Ph.D.
Assistant Professor, Gynecologic Oncology and Reproductive Medicine
Monday, October 26 (All times in CET)
10:00–11:00 (10–11 a.m.)
The next generation of immunotherapies, Part 3
Ecaterina Dumbrava, M.D.
Associate Professor, Investigational Cancer Therapeutics
11:30–12:00 (11:30–12 p.m.)
Decoding the latest leukemia advances, Part 2
Musa Yilmaz, M.D.
Associate Professor, Leukemia
12:00–12:30 (12–12:30 p.m.)
Translating genomic discovery into clinical impact
Andy Futreal, Ph.D.
Chair, Genomic Medicine
Jordi Rodón, M.D., Ph.D.
Professor, Investigational Cancer Therapeutics